Emodin suppresses LPS-induced inflammation in RAW264.7 cells through a PPARγ-dependent pathway

Int Immunopharmacol. 2016 May:34:16-24. doi: 10.1016/j.intimp.2016.02.014. Epub 2016 Feb 22.

Abstract

Inflammation is a defense and protective response to multiple harmful stimuli. Over and uncontrolled inflammation can lead to local tissues or even systemic damages and injuries. Actually, uncontrolled and self-amplified inflammation is the fundament of the pathogenesis of a variety of inflammatory diseases, including sepsis shock, acute lung injury and acute respiratory distress syndrome (ALI/ARDS). Our recent study showed that emodin, the main active component of Radix rhizoma Rhei, could significantly ameliorate LPS-induced ALI/ARDS in mice. However, its underlying signal pathway was not still very clear. Then, the aim of current study was to explore whether emodin could attenuate LPS-induced inflammation in RAW264.7 cells, and its involved potential mechanism. The mRNA and protein expression of ICAM-1, MCP-1 and PPARγ were measured by qRCR and western blotting, the production of TNF-α was evaluated by ELISA. Then, the phosphorylation of NF-κB p65 was also detected by western blotting. And NF-κB p65 DNA binding activity was analyzed by ELISA as well. Meanwhile, siRNA-PPARγ transfection was performed to knockdown PPARγ expression in cells. Our data revealed that LPS-induced the up-regulation of ICAM-1, MCP-1 and TNF-α, LPS-induced the down-regulation of PPARγ, and LPS-enhanced NF-κB p65 activation and DNA binding activity were substantially suppressed by emdoin in RAW264.7 cells. Furthermore, our data also figured out that these effects of emdoin were largely abrogated by siRNA-PPARγ transfection. Taken together, our results indicated that LPS-induced inflammation were potently compromised by emodin very likely through the PPARγ-dependent inactivation of NF-κB in RAW264.7 cells.

Keywords: Emodin; Inflammation; Nuclear factor-κB (NF-κB); Peroxisome proliferators-activated receptor γ (PPARγ); RAW264.7 cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aconitum / immunology
  • Animals
  • Anti-Inflammatory Agents / pharmacology*
  • Disease Models, Animal
  • Emodin / pharmacology*
  • Humans
  • Inflammation / drug therapy*
  • Lipopolysaccharides / immunology
  • Macrophages / drug effects*
  • Macrophages / immunology
  • Mice
  • NF-kappa B / metabolism
  • PPAR gamma / genetics
  • PPAR gamma / metabolism*
  • RAW 264.7 Cells
  • RNA, Small Interfering / genetics
  • Respiratory Distress Syndrome / drug therapy*
  • Signal Transduction / drug effects*
  • Signal Transduction / genetics

Substances

  • Anti-Inflammatory Agents
  • Lipopolysaccharides
  • NF-kappa B
  • PPAR gamma
  • RNA, Small Interfering
  • Emodin